Company page

Orchestra Biomed Holdings, Inc.

Orchestra Biomed Holdings, Inc. (ticker: OBIO) is a public company based in the United States, with a market capitalization of approximately $238.9 million. The company focuses on developing innovative medical technologies aimed at improving patient outcomes. Orchestra Biomed is dedicated to advancing its product pipeline to address unmet medical needs in various therapeutic areas.